TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
HCM

HUTCHMED DRC

Healthcare · Drug Manufacturers - Specialty & Generic

14.10$ +1.4% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Income Statement

HUTCHMED DRC (HCM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 139 million $. Tick rows to compare them in a chart.

Tick rows to compare them in a chart (up to 4)

Income Statement HCM
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
80 153 153 153 162 162 139 139 135 135 139 139 549
167 239 90 90 190 190 84 84 159 159 115 115 548
-86 -86 63 63 -28 -28 55 55 -23 -23 24 24 1.1
79 79 48 48 59 59 36 36 41 41 39 39 162
19 5.8 15 15 17 17 14 14 19 19 16 16 71
-40 -40 77 77 -20 -20 57 57 -5.3 -5.3 23 23 36
-47 -47 -14 -14 -8.1 -8.1 -1.8 -1.8 -18 -18 0.4 0.4 -35
-33 -33 15 15 8.2 8.2 259 259 1.3 1.3 8.7 8.7 20
0.9 0.9 1.4 1.4 2.2 2.2 32 32 0.2 0.2 0.6 0.6 1.7
-34 -34 13 13 6.0 6.0 227 227 1.0 1.0 8.0 8.0 18
-44 -44 -11 -11 -5.0 -5.0 1.3 1.3 -14 -14 4.0 4.0 -21

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?